Karyopharm Therapeutics
KPTI
#8602
Rank
C$0.14 B
Marketcap
$1.13
Share price
14.66%
Change (1 day)
-32.10%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$1.78

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.79. In 2022 the company made an earnings per share (EPS) of -$2.75 a decrease over its 2021 EPS that were of -$2.25.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.78-35.32%
2022-$2.7522.29%
2021-$2.25-39.19%
2020-$3.70-15.48%
2019-$4.383.19%
2018-$4.2511.79%
2017-$3.80-4.44%
2016-$3.97-11.75%
2015-$4.5037.76%
2014-$3.27-74.5%
2013-$12.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.47-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.38-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.03-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.38-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA